Corrigendum to ‘ESPEN guideline: Clinical nutrition in inflammatory bowel disease’ [Clinical Nutrition 36 (2) (2016) 321–347](S0261561416313681)(10.1016/j.clnu.2016.12.027)

Alastair Forbes, Johanna Escher, Xavier H_ebuterne, Stanisław Kłe˛k, Zeljko Krznaric, St_ephane Schneider, Raanan Shamir, Kalina Stardelova, Nicolette Wierdsma, Anthony E. Wiskin, Stephan C. Bischoff

Research output: Contribution to journalErratumAcademicpeer-review

Abstract

The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3”, refer only to the probiotic product used in the cited literature and equivalent products independent from the present product labeling. The authors would like to apologise for any inconvenience caused.
Original languageEnglish
JournalClinical Nutrition
DOIs
Publication statusPublished - 2019

Cite this

Forbes, Alastair ; Escher, Johanna ; H_ebuterne, Xavier ; Kłe˛k, Stanisław ; Krznaric, Zeljko ; Schneider, St_ephane ; Shamir, Raanan ; Stardelova, Kalina ; Wierdsma, Nicolette ; Wiskin, Anthony E. ; Bischoff, Stephan C. / Corrigendum to ‘ESPEN guideline: Clinical nutrition in inflammatory bowel disease’ [Clinical Nutrition 36 (2) (2016) 321–347](S0261561416313681)(10.1016/j.clnu.2016.12.027). In: Clinical Nutrition. 2019.
@article{e459419181ba4bcf8160ad3463f9b261,
title = "Corrigendum to ‘ESPEN guideline: Clinical nutrition in inflammatory bowel disease’ [Clinical Nutrition 36 (2) (2016) 321–347](S0261561416313681)(10.1016/j.clnu.2016.12.027)",
abstract = "The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3”, refer only to the probiotic product used in the cited literature and equivalent products independent from the present product labeling. The authors would like to apologise for any inconvenience caused.",
author = "Alastair Forbes and Johanna Escher and Xavier H_ebuterne and Stanisław Kłe˛k and Zeljko Krznaric and St_ephane Schneider and Raanan Shamir and Kalina Stardelova and Nicolette Wierdsma and Wiskin, {Anthony E.} and Bischoff, {Stephan C.}",
year = "2019",
doi = "10.1016/j.clnu.2019.03.004",
language = "English",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",

}

Corrigendum to ‘ESPEN guideline: Clinical nutrition in inflammatory bowel disease’ [Clinical Nutrition 36 (2) (2016) 321–347](S0261561416313681)(10.1016/j.clnu.2016.12.027). / Forbes, Alastair; Escher, Johanna; H_ebuterne, Xavier; Kłe˛k, Stanisław; Krznaric, Zeljko; Schneider, St_ephane; Shamir, Raanan; Stardelova, Kalina; Wierdsma, Nicolette; Wiskin, Anthony E.; Bischoff, Stephan C.

In: Clinical Nutrition, 2019.

Research output: Contribution to journalErratumAcademicpeer-review

TY - JOUR

T1 - Corrigendum to ‘ESPEN guideline: Clinical nutrition in inflammatory bowel disease’ [Clinical Nutrition 36 (2) (2016) 321–347](S0261561416313681)(10.1016/j.clnu.2016.12.027)

AU - Forbes, Alastair

AU - Escher, Johanna

AU - H_ebuterne, Xavier

AU - Kłe˛k, Stanisław

AU - Krznaric, Zeljko

AU - Schneider, St_ephane

AU - Shamir, Raanan

AU - Stardelova, Kalina

AU - Wierdsma, Nicolette

AU - Wiskin, Anthony E.

AU - Bischoff, Stephan C.

PY - 2019

Y1 - 2019

N2 - The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3”, refer only to the probiotic product used in the cited literature and equivalent products independent from the present product labeling. The authors would like to apologise for any inconvenience caused.

AB - The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3”, refer only to the probiotic product used in the cited literature and equivalent products independent from the present product labeling. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063759309&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30955984

U2 - 10.1016/j.clnu.2019.03.004

DO - 10.1016/j.clnu.2019.03.004

M3 - Erratum

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

ER -